FDA Approves New Drug for Hodgkin Lymphoma

News   Apr 20, 2017 | Original story from National Cancer Institute

 
FDA Approves Pembrolizumab for Hodgkin Lymphoma

Anatomical illustration of lymphoma. Credit: Terese Winslow

 
 
 
 

RELATED NEWS

Academic Redesigns FDA-Approved MabThera to Treat ALS

News

Researchers have redesigned a portion of the FDA-apporved MabThera for better-targeted treatment of ALS.

READ MORE

Regulatory T Cells Play Essential Role in Hair Growth

News

UCSF researchers have shown that faulty immune cells may play a role in the development of Alopecia and other forms of baldness.

READ MORE

Liver Fluke Granulin Structural Fold Provides Wound Healing Opportunity

News

Researchers can now mass produce wound-healing peptides isolated from the spit of the human parasitic liver fluke, a worm that causes liver cancer and kills 26,000 people in Thailand each year.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE